Work

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Year: 2005

Type: article

Study design: Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(05)66374-x

Authors: Luc F Van Gaal, Aila M Rissanen, André J Scheen, Olivier Ziegler, Stephan Rössner

Institutions: Antwerp University Hospital, University of Helsinki, Helsinki University Hospital, University of Liège, Centre Hospitalier Régional et Universitaire de Nancy, Hôpital Jeanne d'Arc, Integrated Cardio Metabolic Centre

Language: English

Topic: Pharmacology and Obesity Treatment

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W1971698096

FWCI: 144.7

Cites: 40

Cited by: 1,513

Related to: 10